Guanhao Biotech(SZ:300238) Xin Lang Cai Jing·2025-08-28 10:29Core Viewpoint - Guanhao Biological (300238.SZ) reported its semi-annual results for 2025, highlighting a significant presence of institutional investors holding 29.07% of its total shares as of August 27, 2025 [1] Institutional Holdings - A total of 9 institutional investors disclosed their holdings in Guanhao Biological, amounting to 77.0696 million shares, which represents 29.07% of the company's total equity [1] - The institutional holding percentage increased by 0.35 percentage points compared to the previous quarter [1] Public Fund Involvement - Three new public funds were disclosed in this period compared to the previous quarter, including Medical Device ETF, China Securities Index Medical Device ETF, and Ping An CSI 2000 Enhanced Strategy ETF [1] Foreign Investment - One new foreign institution, BARCLAYS BANK PLC, disclosed its holdings this period, while Goldman Sachs LLC was not reported in this quarter [1]